Abstract
Drug–target interactions is essential for advancing pharmaceuticals. Traditional drug–target interaction studies rely on labor-intensive laboratory techniques. Still, recent advancements in computing power have elevated the importance of deep learning methods, offering faster, more precise, and cost-effective screening and prediction. Nonetheless, general deep learning methods often yield low-confidence results due to the complex nature of drugs and proteins, bias, limited labeled data, and feature extraction challenges. To address these challenges, a novel two-stage pre-trained framework is proposed for drug–target interactions prediction. In the first stage, pre-trained molecule and protein models develop a comprehensive feature representation, enhancing the framework’s ability to handle drug and protein diversity. This also reduces bias, improving prediction accuracy. In the second stage, a transformer with bilinear pooling and a fully connected layer enables predictions based on feature vectors. Comprehensive experiments were conducted using public datasets from DrugBank and Epigenetic-regulators datasets to evaluate the framework’s effectiveness. The results demonstrate that the proposed framework outperforms the state-of-the-art methods regarding accuracy, area under the receiver operating characteristic curve, recall, and area under the precision-recall curve. The code is available at: https://github.com/DHCGroup/MocFormer.
Author supplied keywords
Cite
CITATION STYLE
Zhang, Y. L., Wang, W. T., Guan, J. H., Jain, D. K., Wang, T. Y., & Roy, S. K. (2024). MocFormer: A Two-Stage Pre-training-Driven Transformer for Drug–Target Interactions Prediction. International Journal of Computational Intelligence Systems, 17(1). https://doi.org/10.1007/s44196-024-00561-1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.